Education
About Us
Working with TipRanks
Follow Us
Cocrystal Pharma Inc (COCP)
NASDAQ:COCP
Total Valuation
Cocrystal Pharma has a market cap or net worth of $13.52M. The enterprise value is $11.98M.
Market Cap$13.52M
Enterprise Value$11.98M
Share Statistics
Cocrystal Pharma has 13,784,065 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding13,784,065
Owned by Insiders23.14%
Owned by Institutions<0.01%
Financial Efficiency
Cocrystal Pharma’s return on equity (ROE) is -1.84 and return on invested capital (ROIC) is -157.81%.
Return on Equity (ROE)-1.84
Return on Assets (ROA)-1.30
Return on Invested Capital (ROIC)-157.81%
Return on Capital Employed (ROCE)-1.62
Revenue Per Employee0.00
Profits Per Employee-1.59M
Employee Count11
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Cocrystal Pharma is ―. Cocrystal Pharma’s PEG ratio is -0.00001.
PE Ratio―
PS Ratio0.00
PB Ratio2.16
Price to Fair Value2.16
Price to FCF-1.25
Price to Operating Cash Flow-1.08
PEG Ratio-0.00001
Income Statement
In the last 12 months, Cocrystal Pharma had revenue of 0.00 and earned -17.50M in profits. Earnings per share was -1.72.
Revenue0.00
Gross Profit-12.54M
Operating Income-17.88M
Pretax Income-17.50M
Net Income-17.50M
EBITDA-17.75M
Earnings Per Share (EPS)-1.72
Cash Flow
In the last 12 months, operating cash flow was -9.80M and capital expenditures -12.56K, giving a free cash flow of -9.82M billion.
Operating Cash Flow-9.80M
Free Cash Flow-9.82M
Free Cash Flow per Share-0.71
Dividends & Yields
Cocrystal Pharma pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.40
52-Week Price Change-61.90%
50-Day Moving Average1.04
200-Day Moving Average1.39
Relative Strength Index (RSI)40.37
Average Volume (3m)3.12M
Important Dates
Cocrystal Pharma upcoming earnings date is Apr 6, 2026, TBA (Confirmed).
Last Earnings DateNov 14, 2025
Next Earnings DateApr 6, 2026
Ex-Dividend Date―
Financial Position
Cocrystal Pharma as a current ratio of 4.77, with Debt / Equity ratio of 20.64%
Current Ratio4.77
Quick Ratio4.77
Debt to Market Cap0.00
Net Debt to EBITDA0.46
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Cocrystal Pharma has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Cocrystal Pharma EV to EBITDA ratio is -0.72, with an EV/FCF ratio of -0.76.
EV to Sales0.00
EV to EBITDA-0.72
EV to Free Cash Flow-0.76
EV to Operating Cash Flow-0.76
Balance Sheet
Cocrystal Pharma has $7.73M in cash and marketable securities with $1.58M in debt, giving a net cash position of $6.15M billion.
Cash & Marketable Securities$7.73M
Total Debt$1.58M
Net Cash$6.15M
Net Cash Per Share$0.45
Tangible Book Value Per Share$0.94
Margins
Gross margin is 16.18%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin16.18%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Cocrystal Pharma is $10.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$10.00
Price Target Upside941.67% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast49.10%